Insider Transactions in Q1 2022 at Altimmune, Inc. (ALT)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 30
2022
|
Vipin K Garg President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,007
-1.04%
|
$18,042
$6.05 P/Share
|
|
Feb 28
2022
|
Matthew Scott Harris Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
30,000
-72.21%
|
$210,000
$7.52 P/Share
|
|
Feb 28
2022
|
Matthew Scott Harris Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+41.93%
|
$30,000
$1.92 P/Share
|
|
Feb 28
2022
|
Vipin K Garg President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,007
-1.03%
|
$21,049
$7.41 P/Share
|
|
Feb 01
2022
|
M Scot Roberts Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,183
-10.98%
|
$15,281
$7.98 P/Share
|
|
Feb 01
2022
|
M Scot Roberts Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,166
+23.67%
|
-
|
|
Feb 01
2022
|
Vipin K Garg President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,655
-2.55%
|
$53,585
$7.98 P/Share
|
|
Feb 01
2022
|
Vipin K Garg President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,545
+5.22%
|
-
|
|
Feb 01
2022
|
Matthew Scott Harris Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,183
-15.9%
|
$15,281
$7.98 P/Share
|
|
Feb 01
2022
|
Matthew Scott Harris Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,166
+30.99%
|
-
|
|
Jan 31
2022
|
M Scot Roberts Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,106
+13.31%
|
$12,636
$6.86 P/Share
|
|
Jan 31
2022
|
Vipin K Garg President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
2,757
+0.96%
|
$16,542
$6.86 P/Share
|
|
Jan 31
2022
|
Matthew Scott Harris Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,800
+19.23%
|
$10,800
$6.86 P/Share
|
|
Jan 30
2022
|
Vipin K Garg President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,355
-0.83%
|
$16,485
$7.2 P/Share
|
|
Jan 25
2022
|
David Drutz Director |
BUY
Exercise of conversion of derivative security
|
Direct |
70
+0.39%
|
$140
$2.4 P/Share
|